Abstract
The Malian pharmacovigilance program has been associated with modest growth over the past years. The purpose of this chapter is to assess the current state of pharmacovigilance (PV) in Mali and the adverse drug reactions reported to the National Pharmacovigilance Center of Mali. The profiles and number of adverse drug reactions (ADRs), the degree of toxicity, and the WHO and Naranjo scores are evaluated. We found that three university teaching hospitals in Mali conducted such PV studies. Our results showed that although there is a recognition of the need for PV, the practice was very limited. Only 67.6% of participant practitioners had an accepted knowledge for PV and its methodology. This situation is attributed to the insufficient knowledge about what can or should be reported in PV and a lack of a reliable notification process. Nevertheless, this study highlighted the profile of commonly used ADRs and the problems inherent to systematic reporting.
Original language | English (US) |
---|---|
Title of host publication | Drug Safety in Developing Countries |
Subtitle of host publication | Achievements and Challenges |
Publisher | Elsevier |
Pages | 557-568 |
Number of pages | 12 |
ISBN (Electronic) | 9780128198377 |
ISBN (Print) | 9780128204122 |
DOIs | |
State | Published - Jan 1 2020 |
Keywords
- Mali
- Pharmacovigilance
- adverse drug reaction
- drug safety
ASJC Scopus subject areas
- Economics, Econometrics and Finance(all)
- General Business, Management and Accounting